Acute Lymphoblastic Leukemia and Associated HLA-A, B, DRB1, and DQB1 Molecules: A Moroccan Pediatric Case–Control Study
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115295 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Khalid Laaziri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Biodiversity Laboratory, Ain Chock Faculty, Science Hassan II University, Casablanca 20000, Morocco. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, HLA-A Antigens, HLA-DRB1 Chains, HLA-DQ beta-Chains. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Leukemia constitutes approximately one-third of all pediatric cancers, with acute lymphoblastic leukemia (ALL) comprising roughly 80% of pediatric leukemia instances. This study sought to ascertain the prevalence of HLA A, B, DR, and DQ allele groups linked with pediatric acute leukemia. We recruited 70 Moroccan children diagnosed with acute lymphoblastic leukemia (ALL), 39 of whom had BCP-ALL and were eligible for hematopoietic stem cell transplantation, compared to a control group of 136 healthy children. Patients and controls were subjected to HLA class I and II typing, utilizing either sequence-specific primers (SSPs) or sequence-specific oligonucleotides (SSOs) in polymerase chain reaction-based techniques. The findings indicated significantly elevated frequencies of HLA-A*68 and B*14 in pediatric patients with ALL relative to the control group (p = 0.001 and p = 0.02, respectively). The frequencies of HLA-DRB1*01 and DQB1*05 allele groups were considerably elevated in children with ALL and BCP-ALL compared to the controls (p < 0.01 for both). The findings of our study indicate that HLA-A*68, -B*14, -DRB1*01, and DQB1*05 may serve as potential predisposing immunogenetic variables for the development of juvenile acute lymphoblastic leukemia (ALL). Nonetheless, additional research including a bigger sample considering other regions of Morocco would be beneficial to more accurately delineate the association between the HLA system and ALL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology and Biodiversity Laboratory, Ain Chock Faculty, Science Hassan II University, Casablanca 20000, Morocco.
- Laboratory of Immunology and HLA, Center of Clinical Research, Mohammed VI University Hospital, Marrakech 40080, Morocco.
- Laboratory of Agro-Industrial and Medical Biotechnology, Experimental Oncology and Natural Substances Team, Cellular and Molecular Immunopharmacology, Faculty of Sciences and Technology, Sultan Moulay Slimane University…
- Department of Pediatric Hematology and Oncology, Mohammed VI University Hospital, Marrakech 40080, Morocco.
- Bioscience Research Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech 40080, Morocco.
ORCID-Profile: Abdelmajid Zyad, Mounia Ammara, Abdellah Naya
Zitieren
APA
Laaziri, K., Zyad, A., Laaziaf, E. M., Houdzi, J. E., Elhanafi, F., Brahim, I., Lakhouaja, N., Hazime, R., Ammara, M., Naya, A., & Admou, B. (2025). Acute Lymphoblastic Leukemia and Associated HLA-A, B, DRB1, and DQB1 Molecules: A Moroccan Pediatric Case–Control Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115295
Vancouver
Laaziri K, Zyad A, Laaziaf EM, Houdzi JE, Elhanafi F, Brahim I, et al. Acute Lymphoblastic Leukemia and Associated HLA-A, B, DRB1, and DQB1 Molecules: A Moroccan Pediatric Case–Control Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115295
BibTeX
@article{Laaziri2025,
author = {Laaziri, Khalid and Zyad, Abdelmajid and Laaziaf, El Mehdi and Houdzi, Jamila El and Elhanafi, Fatimaezzahra and Brahim, Ikram and Lakhouaja, Nadia and Hazime, Raja and Ammara, Mounia and Naya, Abdellah and Admou, Brahim},
title = {Acute Lymphoblastic Leukemia and Associated HLA-A, B, DRB1, and DQB1 Molecules: A Moroccan Pediatric Case–Control Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115295}
}
EUVIMED